EXOR (EXO.AS) generated 2.86 B EUR of operating cash flow and 2.86 B EUR of free cash flow in fiscal year 2025, up 5,991.5 % year on year.
EXOR (EXO.AS) generated 2.86 B EUR of operating cash flow in fiscal year 2025. Free cash flow was 2.86 B EUR, up 5,991.5 % year on year. The company paid 93.0 M EUR in dividends and spent 1,000 M EUR on share buybacks. The net change in cash over the year was 1.24 B EUR. Over the whole period free cash flow compounds at 5.0 % a year. The series covers 4 fiscal years, from 2022 to 2025. All figures are stated in EUR and are taken from the company's own published annual accounts, with no restatements or adjustments of our own. The statement keeps the natural cash-flow sign convention: cash outflows are negative.
Fiscal year end: December
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Net income | 4.23B | 4.19B | 14.7B | -3.79B |
| Depreciation & amortization | 1.85B | 2.05B | 0.00B | — |
| Asset impairment | — | — | — | — |
| Stock-based compensation | — | 100M | 24.0M | — |
| Deferred taxes | — | — | — | — |
| (Gain)/loss on sale of assets | — | — | — | — |
| (Gain)/loss on sale of businesses and investments | -0.16B | 0.00B | -16.3B | 5.81B |
| Income from equity method investments | — | — | — | — |
| Provisions and restructuring | — | — | — | — |
| Change in working capital | -727M | -1,776M | 3.00M | 69.0M |
| Other operating activities (as reported) | -273M | -536M | 691M | 150M |
| Unallocated operating remainder | — | — | 963M | 625M |
| Operating cash flow | 4.92B | 4.03B | 0.05B | 2.86B |
| Operating cash flow — YoY growth | — | -18.02 % | -98.83 % | 5,991.49 % |
| Capex | -2.45B | -2.81B | — | — |
| Free Cash Flow | 2.47B | 1.22B | 0.05B | 2.86B |
| Free Cash Flow — YoY growth | — | -50.53 % | -96.15 % | 5,991.49 % |
Figures in EUR
Fiscal year end: December
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Capex | -2.45B | -2.81B | — | — |
| Proceeds from sale of PP&E | — | — | — | — |
| Business acquisitions | -0.87B | -4.61B | 0.00B | — |
| Business divestitures | 6.97B | 0.00B | — | — |
| Purchases/sales of investments | -7.65B | 2.37B | 0.07B | -0.01B |
| Long-term investments | -104M | -3,688M | -143M | -10.0M |
| Unallocated investing remainder | 0.00M | 0.00M | 13.0M | 47.0M |
| Investing cash flow | -4.10B | -8.73B | -0.06B | 0.02B |
Figures in EUR
Fiscal year end: December
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Debt issuance | 2.90B | 8.63B | 1.09B | 0.75B |
| Debt repayment | -2.39B | -3.69B | -0.72B | -1.16B |
| Share issuance | 1.00M | 4.00M | 6.00M | — |
| Share buybacks | -797M | -996M | -249M | -1,000M |
| Tax withholding on RSU/option vesting | — | — | — | — |
| Dividends paid | -601M | -716M | -99.0M | -93.0M |
| Other financing activities | 3,020M | -1,121M | -87.0M | -132M |
| Financing cash flow | 2.13B | 2.11B | -0.06B | -1.63B |
Figures in EUR
Fiscal year end: December
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Operating cash flow | 4.92B | 4.03B | 0.05B | 2.86B |
| Investing cash flow | -4.10B | -8.73B | -0.06B | 0.02B |
| Financing cash flow | 2.13B | 2.11B | -0.06B | -1.63B |
| Foreign exchange effect | 137M | -306M | 21.0M | -15.0M |
| Net change in cash | 3.09B | -2.90B | -0.05B | 1.24B |
| Income taxes paid (cash) | — | — | -22.0M | -38.0M |
| Interest paid (cash) | — | 0.00M | -87.0M | -93.0M |
Figures in EUR
